What do systematic reviews say?

Trifocal intraocular lenses vs bifocal intraocular lenses after cataract extraction among participants with presbyopia

• Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 107 participants
  Low

Trifocal intraocular lenses vs bifocal intraocular lenses after cataract extraction among participants with presbyopia

The review found no eligible studies for this question.

• Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Trifocal intraocular lenses vs bifocal intraocular lenses after cataract extraction among participants with presbyopia

The review found no eligible studies for this question.

• Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Trifocal intraocular lenses vs bifocal intraocular lenses after cataract extraction among participants with presbyopia

• Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with… 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 129 participants
  Low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

The review found no eligible studies for this question.

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

It is very uncertain whether surfactant treatment guided by rapid tests for surfactant deficiency changes mortality prior to hospital discharge№ of participants: 562 (3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (very low certainty).

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  RR 1.25 [0.65, 2.41]
  Studies not reported
  Very low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in bronchopulmonary dysplasia№ of participants: 562(3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  RR 0.9 [0.61, 1.32]
  Studies not reported
  Low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

The review found no eligible studies for this question.

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in surfactant utilization № of participants: 562 (3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  RR 0.97 [0.85, 1.11]
  Studies not reported
  Low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in any pneumothorax№ of participants: 506(2 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  RR 0.53 [0.15, 1.92]
  Studies not reported
  Low

Surfactant treatment guided by rapid tests for surfactant deficiency vs surfactant therapy provided to preterm infants with respiratory distress syndrome diagnosed on clinical and radiologic criteria

The review found no eligible studies for this question.

• Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The intervention probably leads to lower diarrhoea prevalence (Children < 5a) (moderate certainty).

• Interventions to improve sanitation for preventing diarrhoea 2023 · Cochrane Headline outcomes only
  RR 0.82 [0.69, 0.98]
  7 studies · 28909 participants
  Moderate

Intervention not reported

The intervention may leads to lower diarrhoea prevalence (All ages) (low certainty).

• Interventions to improve sanitation for preventing diarrhoea 2023 · Cochrane Headline outcomes only
  RR 0.85 [0.76, 0.95]
  17 studies · 83938 participants
  Low

Intervention not reported

The intervention may leads to lower diarrhoea prevalence (Children < 5) (low certainty).

• Interventions to improve sanitation for preventing diarrhoea 2023 · Cochrane Headline outcomes only
  RR 0.87 [0.77, 0.97]
  14 studies · 60024 participants
  Low

Intervention not reported

The intervention showed no clear difference in diarrhoea prevalence (All ages) (low certainty).

• Interventions to improve sanitation for preventing diarrhoea 2023 · Cochrane Headline outcomes only
  RR 0.89 [0.73, 1.08]
  7 studies · 40129 participants
  Low

Intervention not reported

The intervention showed no clear difference in diarrhoea prevalence (Children < 5) (low certainty).

• Interventions to improve sanitation for preventing diarrhoea 2023 · Cochrane Headline outcomes only
  RR 0.98 [0.83, 1.16]
  4 studies · 16215 participants
  Low

Intervention not reported

The intervention showed no clear difference in diarrhoea prevalence (Children < 5a) (low certainty).

• Interventions to improve sanitation for preventing diarrhoea 2023 · Cochrane Headline outcomes only
  RR 0.85 [0.69, 1.06]
  3 studies · 14900 participants
  Low

Intervention not reported

The intervention may leads to lower diarrhoea prevalence (All ages) (low certainty).

• Interventions to improve sanitation for preventing diarrhoea 2023 · Cochrane Headline outcomes only
  RR 0.61 [0.5, 0.74]
  23 studies · 117639 participants
  Low

Intervention not reported

It is very uncertain whether the intervention changes diarrhoea prevalence (Children < 5) (very low certainty).

• Interventions to improve sanitation for preventing diarrhoea 2023 · Cochrane Headline outcomes only
  RR 0.64 [0.43, 0.96]
  9 studies · 8453 participants
  Very low

Intervention not reported

• Family presence during resuscitation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 493 participants
  Very low